Cargando…

The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices

INTRODUCTION: Understanding clinical trial experiences can illuminate opportunities to optimize trial design and management, with potential benefits for recruitment and retention. This study sought to better understand clinical trial participant experiences and attitudes within spinal muscular atrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Ilse S., Mazzella, Allison J., Belter, Lisa T., Curry, Mary A., Cruz, Rosángel E., Jarecki, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149668/
https://www.ncbi.nlm.nih.gov/pubmed/35635603
http://dx.doi.org/10.1007/s40120-022-00360-w
_version_ 1784717251458367488
author Peterson, Ilse S.
Mazzella, Allison J.
Belter, Lisa T.
Curry, Mary A.
Cruz, Rosángel E.
Jarecki, Jill
author_facet Peterson, Ilse S.
Mazzella, Allison J.
Belter, Lisa T.
Curry, Mary A.
Cruz, Rosángel E.
Jarecki, Jill
author_sort Peterson, Ilse S.
collection PubMed
description INTRODUCTION: Understanding clinical trial experiences can illuminate opportunities to optimize trial design and management, with potential benefits for recruitment and retention. This study sought to better understand clinical trial participant experiences and attitudes within spinal muscular atrophy (SMA), and how the evolving treatment landscape and participant characteristics may predict attitudes. METHODS: A survey was developed following a review of published literature and discussions with caregivers of SMA trial participants. This was distributed via email to known trial participants in Cure SMA’s database, announcements in Cure SMA’s newsletter, and emails to SMA clinical trial principal investigators. RESULTS: Seventy complete surveys reflecting unique clinical trial experiences were included in analysis. Responses revealed positive attitudes about clinical trial management overall. Top motivators for trial participation included clinical benefit, investigational drug access, and the opportunity to help others. Top concerns were safety, whether benefits would justify risks, and concerns about pain accompanying tests. The greatest stressors were fear of pain, adverse event concerns, and challenges managing medical complications of SMA. Top benefits of trial participation were hope for a better future, helping others, and relationships with the study team. In regression analysis, participant gender, age, and race all emerged as significant predictors (p < 0.05) of motivators, concerns, stressors, and benefits, as did respondent type, knowledge about SMA, distance to the trial site, and treatment era. Top recommendations for improving study management all related to receiving more information. CONCLUSION: This research provides new perspective on patient experiences in SMA clinical trials. It underscores the importance of information and efforts to anticipate and accommodate participant needs. These findings may inform study design and interactions with research participants. They may become especially important in supporting recruitment and retention as more treatment options become available. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40120-022-00360-w.
format Online
Article
Text
id pubmed-9149668
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-91496682022-06-02 The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices Peterson, Ilse S. Mazzella, Allison J. Belter, Lisa T. Curry, Mary A. Cruz, Rosángel E. Jarecki, Jill Neurol Ther Original Research INTRODUCTION: Understanding clinical trial experiences can illuminate opportunities to optimize trial design and management, with potential benefits for recruitment and retention. This study sought to better understand clinical trial participant experiences and attitudes within spinal muscular atrophy (SMA), and how the evolving treatment landscape and participant characteristics may predict attitudes. METHODS: A survey was developed following a review of published literature and discussions with caregivers of SMA trial participants. This was distributed via email to known trial participants in Cure SMA’s database, announcements in Cure SMA’s newsletter, and emails to SMA clinical trial principal investigators. RESULTS: Seventy complete surveys reflecting unique clinical trial experiences were included in analysis. Responses revealed positive attitudes about clinical trial management overall. Top motivators for trial participation included clinical benefit, investigational drug access, and the opportunity to help others. Top concerns were safety, whether benefits would justify risks, and concerns about pain accompanying tests. The greatest stressors were fear of pain, adverse event concerns, and challenges managing medical complications of SMA. Top benefits of trial participation were hope for a better future, helping others, and relationships with the study team. In regression analysis, participant gender, age, and race all emerged as significant predictors (p < 0.05) of motivators, concerns, stressors, and benefits, as did respondent type, knowledge about SMA, distance to the trial site, and treatment era. Top recommendations for improving study management all related to receiving more information. CONCLUSION: This research provides new perspective on patient experiences in SMA clinical trials. It underscores the importance of information and efforts to anticipate and accommodate participant needs. These findings may inform study design and interactions with research participants. They may become especially important in supporting recruitment and retention as more treatment options become available. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40120-022-00360-w. Springer Healthcare 2022-05-30 /pmc/articles/PMC9149668/ /pubmed/35635603 http://dx.doi.org/10.1007/s40120-022-00360-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Peterson, Ilse S.
Mazzella, Allison J.
Belter, Lisa T.
Curry, Mary A.
Cruz, Rosángel E.
Jarecki, Jill
The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices
title The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices
title_full The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices
title_fullStr The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices
title_full_unstemmed The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices
title_short The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices
title_sort cure sma clinical trial experience survey: a study of trial participant perspectives on clinical trial management and patient-centric management practices
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149668/
https://www.ncbi.nlm.nih.gov/pubmed/35635603
http://dx.doi.org/10.1007/s40120-022-00360-w
work_keys_str_mv AT petersonilses thecuresmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT mazzellaallisonj thecuresmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT belterlisat thecuresmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT currymarya thecuresmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT cruzrosangele thecuresmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT jareckijill thecuresmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT petersonilses curesmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT mazzellaallisonj curesmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT belterlisat curesmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT currymarya curesmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT cruzrosangele curesmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices
AT jareckijill curesmaclinicaltrialexperiencesurveyastudyoftrialparticipantperspectivesonclinicaltrialmanagementandpatientcentricmanagementpractices